ArticleCell death & disease2013

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

M R Milone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.